Outset Medical Price to Book Ratio 2019-2025 | OM
Historical price to book ratio values for Outset Medical (OM) over the last 10 years. The current price to book ratio for Outset Medical as of January 15, 2026 is 0.70.
| Outset Medical Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-01-15 | 5.26 | 0.66 | |
| 2025-09-30 | 14.12 | $7.99 | 1.77 |
| 2025-06-30 | 19.21 | $8.71 | 2.20 |
| 2025-03-31 | 11.06 | $9.59 | 1.15 |
| 2024-12-31 | 16.65 | $7.60 | 2.19 |
| 2024-09-30 | 10.16 | $13.65 | 0.74 |
| 2024-06-30 | 57.75 | $19.75 | 2.92 |
| 2024-03-31 | 33.30 | $27.03 | 1.23 |
| 2023-12-31 | 81.15 | $36.62 | 2.22 |
| 2023-09-30 | 163.20 | $45.44 | 3.59 |
| 2023-06-30 | 328.05 | $55.32 | 5.93 |
| 2023-03-31 | 276.00 | $65.89 | 4.19 |
| 2022-12-31 | 387.30 | $76.10 | 5.09 |
| 2022-09-30 | 238.95 | $86.64 | 2.76 |
| 2022-06-30 | 222.90 | $96.76 | 2.30 |
| 2022-03-31 | 681.00 | $108.55 | 6.27 |
| 2021-12-31 | 691.35 | $118.72 | 5.82 |
| 2021-09-30 | 741.60 | $130.66 | 5.68 |
| 2021-06-30 | 749.70 | $139.84 | 5.36 |
| 2021-03-31 | 815.85 | $107.19 | 7.61 |
| 2020-12-31 | 852.60 | $115.32 | 7.39 |
| 2020-09-30 | 750.00 | $124.41 | 6.03 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.099B | $0.114B |
| Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.977B | 41.61 |
| Tempus AI (TEM) | United States | $12.325B | 0.00 |
| Doximity (DOCS) | United States | $7.582B | 31.22 |
| Hims & Hers Health (HIMS) | United States | $7.130B | 58.00 |
| IRHYTHM HLDGS (IRTC) | United States | $5.259B | 0.00 |
| Hinge Health (HNGE) | United States | $3.411B | 0.00 |
| Heartflow (HTFL) | United States | $2.979B | 0.00 |
| Privia Health (PRVA) | United States | $2.811B | 175.77 |
| Inspire Medical Systems (INSP) | United States | $2.704B | 44.74 |
| 10x Genomics (TXG) | United States | $2.647B | 0.00 |
| Omnicell (OMCL) | United States | $2.276B | 46.53 |
| Azenta (AZTA) | United States | $1.817B | 74.53 |
| Clover Health Investments (CLOV) | United States | $1.452B | 0.00 |
| Enovis (ENOV) | United States | $1.388B | 7.29 |
| Schrodinger (SDGR) | United States | $1.350B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.250B | 0.00 |
| Phreesia (PHR) | United States | $0.971B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.865B | 0.00 |
| Talkspace (TALK) | United States | $0.628B | 126.33 |
| Standard BioTools (LAB) | United States | $0.611B | 0.00 |
| Claritev (CTEV) | United States | $0.504B | 0.00 |
| Evolent Health (EVH) | United States | $0.435B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.348B | 0.00 |
| Carlsmed (CARL) | United States | $0.339B | 0.00 |
| TruBridge (TBRG) | United States | $0.329B | 15.14 |
| Zepp Health (ZEPP) | Netherlands | $0.299B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.293B | 0.00 |
| CapsoVision (CV) | United States | $0.276B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.258B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.196B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.174B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.169B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.163B | 0.00 |
| CareCloud (CCLD) | United States | $0.122B | 6.67 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| HeartBeam (BEAT) | United States | $0.079B | 0.00 |
| American Well (AMWL) | United States | $0.077B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.072B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.062B | 0.00 |
| 111 (YI) | China | $0.050B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.042B | 0.00 |
| Precipio (PRPO) | United States | $0.042B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.023B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.021B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.014B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |